Ayaz Muhammad, Junaid Muhammad, Ahmed Jawad, Ullah Farhat, Sadiq Abdul, Ahmad Sajjad, Imran Muhammad
Department of Pharmacy, University of Malakand, Khyber Pakhtoonkhwa 18000, KPK, Pakistan.
BMC Complement Altern Med. 2014 May 3;14:145. doi: 10.1186/1472-6882-14-145.
We investigated Polygonum hydropiper L. (P. hydropiper) for phenolic contents, antioxidant, anticholinesterase activities, in an attempt to rationalize its use in neurological disorders.
Plant crude extract (Ph.Cr), its subsequent fractions: n-hexane (Ph.Hex), chloroform (Ph.Chf), ethyl acetate (Ph.EtAc), n-Butanol (Ph.Bt), aqueous (Ph.Aq) and saponins (Ph.Sp) were evaluated for 1,1-diphenyl,2-picrylhydrazyl (DPPH), 2,2-azinobis[3-ethylbenzthiazoline]-6-sulfonic acid (ABTS) free radical scavenging potential. Further, acetylcholinesterase (AChE) & butyrylcholinesterase (BChE) inhibitory activities were performed using Ellman's assay. Moreover, total phenolic contents of plant extracts were determined and expressed in mg of gallic acid equivalent per gram of dry sample (mg GAE/g dry weight).
Among different fractions, Ph.Cr (90.82), Ph.Chf (178.16), Ph.EtAc (203.44) and Ph.Bt (153.61) exhibited high phenolic contents. All fractions showed concentration dependent DPPH scavenging activity, with Ph.EtAc 71.33% (IC50 15 μg/ml), Ph.Bt 71.40% (IC50 3 μg/ml) and Ph.Sp 71.40% (IC50 35 μg/ml) were most potent. The plant extracts exhibited high ABTS scavenging ability i.e. Ph.Bt (91.03%), Ph.EtAc (90.56%), Ph.Sp (90.84%), Ph.Aq (90.56%) with IC50<0.01 μg/ml. All fractions showed moderate to high AChE inhibitory activity as; Ph.Cr, 86.87% (IC50 330 μg/ml), Ph.Hex, 87.49% (IC50 35 μg/ml), Ph.Chf, 84.76% (IC50 55 μg/ml), Ph.Sp, 87.58% (IC50 108 μg/ml) and Ph.EtAc 79.95% (IC50 310 μg/ml) at 1 mg/ml). Furthermore the BChE inhibitory activity was most prominent in Ph.Hex 90.30% (IC50 40 μg/ml), Ph.Chf 85.94% (IC50 215 μg/ml), Ph.Aq 87.62% (IC50 3 μg/ml) and Ph.EtAc 81.01% (IC50 395 μg/ml) fractions.
In this study, for the first time, we determined phenolic contents, isolated crude saponins, investigated antioxidant and anticholinestrase potential of P. hydropiper extracts. The results indicate that P. hydropiper is enriched with potent bioactive compounds and warrant further investigation by isolation and structural elucidation to find novel and affordable compounds for the treatment of various neurological disorders.
我们研究了水蓼的酚类成分、抗氧化和抗胆碱酯酶活性,旨在使其在神经系统疾病中的应用合理化。
对植物粗提物(Ph.Cr)及其后续馏分:正己烷(Ph.Hex)、氯仿(Ph.Chf)、乙酸乙酯(Ph.EtAc)、正丁醇(Ph.Bt)、水相(Ph.Aq)和皂苷(Ph.Sp)进行1,1-二苯基-2-苦基肼(DPPH)、2,2'-联氮-双-(3-乙基苯并噻唑啉-6-磺酸)(ABTS)自由基清除能力评估。此外,使用埃尔曼法进行乙酰胆碱酯酶(AChE)和丁酰胆碱酯酶(BChE)抑制活性测定。此外,测定植物提取物的总酚含量,并以每克干样品中没食子酸当量的毫克数(mg GAE/g干重)表示。
在不同馏分中,Ph.Cr(90.82)、Ph.Chf(178.16)、Ph.EtAc(203.44)和Ph.Bt(153.61)表现出较高的酚类含量。所有馏分均表现出浓度依赖性的DPPH清除活性,其中Ph.EtAc为71.33%(IC50为15μg/ml)、Ph.Bt为71.40%(IC50为3μg/ml)和Ph.Sp为71.40%(IC50为35μg/ml)最为有效。植物提取物表现出较高的ABTS清除能力,即Ph.Bt(91.03%)、Ph.EtAc(90.56%)、Ph.Sp(90.84%)、Ph.Aq(90.56%),IC50<0.01μg/ml。所有馏分均表现出中度至高的AChE抑制活性,如在1mg/ml时,Ph.Cr为86.87%(IC50为330μg/ml)、Ph.Hex为87.49%(IC50为35μg/ml)、Ph.Chf为84.76%(IC50为55μg/ml)、Ph.Sp为87.58%(IC50为108μg/ml)、Ph.EtAc为79.95%(IC50为310μg/ml)。此外BChE抑制活性在Ph.Hex中最为显著,为90.30%(IC50为40μg/ml),Ph.Chf为85.94%(IC50为215μg/ml),Ph.Aq为87.62%(IC50为μg/ml),Ph.EtAc为81.01%(IC50为395μg/ml)馏分。
在本研究中,我们首次测定了水蓼提取物的酚类含量,分离了粗皂苷,研究了其抗氧化和抗胆碱酯酶潜力。结果表明,水蓼富含强效生物活性化合物,有必要通过分离和结构解析进行进一步研究,以寻找用于治疗各种神经系统疾病的新型且经济实惠的化合物。